133 related articles for article (PubMed ID: 16217836)
1. Bayesian multivariate hierarchical transformation models for ROC analysis.
O'Malley AJ; Zou KH
Stat Med; 2006 Feb; 25(3):459-79. PubMed ID: 16217836
[TBL] [Abstract][Full Text] [Related]
2. A Bayesian hierarchical non-linear regression model in receiver operating characteristic analysis of clustered continuous diagnostic data.
Zou KH; O'Malley AJ
Biom J; 2005 Aug; 47(4):417-27. PubMed ID: 16161801
[TBL] [Abstract][Full Text] [Related]
3. Bayesian regression methodology for estimating a receiver operating characteristic curve with two radiologic applications: prostate biopsy and spiral CT of ureteral stones.
Omalley AJ; Zou KH; Fielding JR; Tempany CM
Acad Radiol; 2001 Aug; 8(8):713-25. PubMed ID: 11508750
[TBL] [Abstract][Full Text] [Related]
4. Bayesian semiparametric estimation of covariate-dependent ROC curves.
Rodríguez A; Martínez JC
Biostatistics; 2014 Apr; 15(2):353-69. PubMed ID: 24174579
[TBL] [Abstract][Full Text] [Related]
5. Statistical validation based on parametric receiver operating characteristic analysis of continuous classification data.
Zou KH; Warfield SK; Fielding JR; Tempany CM; William MW; Kaus MR; Jolesz FA; Kikinis R
Acad Radiol; 2003 Dec; 10(12):1359-68. PubMed ID: 14697004
[TBL] [Abstract][Full Text] [Related]
6. Flexible regression models for ROC and risk analysis, with or without a gold standard.
Branscum AJ; Johnson WO; Hanson TE; Baron AT
Stat Med; 2015 Dec; 34(30):3997-4015. PubMed ID: 26239173
[TBL] [Abstract][Full Text] [Related]
7. Estimating receiver operating characteristic curves with covariates when there is no perfect reference test for diagnosis of Johne's disease.
Wang C; Turnbull BW; Gröhn YT; Nielsen SS
J Dairy Sci; 2006 Aug; 89(8):3038-46. PubMed ID: 16840620
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
[TBL] [Abstract][Full Text] [Related]
9. Electrophoretic subforms of free prostate-specific antigen in serum as promising diagnostic tool in prostate cancer diagnostics.
Jung K; Hoesel W; Reiche J; Deger S; Kramer J; Loening SA; Lein M; Stephan C
Urology; 2007 Feb; 69(2):320-5. PubMed ID: 17320672
[TBL] [Abstract][Full Text] [Related]
10. Comparison of adjustment methods for stratified two-sample tests in the context of ROC analysis.
Zou KH; Carlsson MO; Yu CR
Biom J; 2012 Mar; 54(2):249-63. PubMed ID: 22378312
[TBL] [Abstract][Full Text] [Related]
11. Indonesian prostate cancer risk calculator (IPCRC): an application for predicting prostate cancer risk (a multicenter study).
Yuri P; Wangge G; Abshari F; Satjakoesoemah AI; Perdana NR; Wijaya CD; Tansol C; Tigor A; Safriadi F; Kadar DD; Warli SM; Rochadi S; Danarto ; Hakim L; Djatisoesanto W; Hardjowijoto S; Mochtar CA; Umbas R; Hamid AR
Acta Med Indones; 2015 Apr; 47(2):95-103. PubMed ID: 26260551
[TBL] [Abstract][Full Text] [Related]
12. Semi-parametric ROC regression analysis with placement values.
Cai T
Biostatistics; 2004 Jan; 5(1):45-60. PubMed ID: 14744827
[TBL] [Abstract][Full Text] [Related]
13. Empirical Bayes estimates generated in a hierarchical summary ROC analysis agreed closely with those of a full Bayesian analysis.
Macaskill P
J Clin Epidemiol; 2004 Sep; 57(9):925-32. PubMed ID: 15504635
[TBL] [Abstract][Full Text] [Related]
14. Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.
Graefen M; Karakiewicz PI; Cagiannos I; Hammerer PG; Haese A; Palisaar J; Huland E; Scardino PT; Kattan MW; Huland H
J Urol; 2002 Mar; 167(3):1306-9. PubMed ID: 11832719
[TBL] [Abstract][Full Text] [Related]
15. Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators.
Nam RK; Kattan MW; Chin JL; Trachtenberg J; Singal R; Rendon R; Klotz LH; Sugar L; Sherman C; Izawa J; Bell D; Stanimirovic A; Venkateswaran V; Diamandis EP; Yu C; Loblaw DA; Narod SA
J Clin Oncol; 2011 Aug; 29(22):2959-64. PubMed ID: 21690464
[TBL] [Abstract][Full Text] [Related]
16. Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.
Johnson SB; Hamstra DA; Jackson WC; Zhou J; Foster B; Foster C; Song Y; Li D; Palapattu GS; Kunju L; Mehra R; Sandler H; Feng FY
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):275-81. PubMed ID: 23886418
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension.
Wang L; Mullerad M; Chen HN; Eberhardt SC; Kattan MW; Scardino PT; Hricak H
Radiology; 2004 Jul; 232(1):133-9. PubMed ID: 15166321
[TBL] [Abstract][Full Text] [Related]
18. Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy.
Cantiello F; Russo GI; Ferro M; Cicione A; Cimino S; Favilla V; Perdonà S; Bottero D; Terracciano D; De Cobelli O; Morgia G; Damiano R
Urol Oncol; 2015 Apr; 33(4):163.e15-23. PubMed ID: 25575715
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy.
Giesing M; Suchy B; Driesel G; Molitor D
BJU Int; 2010 Apr; 105(7):1000-10. PubMed ID: 19818074
[TBL] [Abstract][Full Text] [Related]
20. Assessing the diagnostic accuracy of a sequence of tests.
Thompson ML
Biostatistics; 2003 Jul; 4(3):341-51. PubMed ID: 12925502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
